Diabetic Ketoacidosis Class Action Lawsuit
The U.S. Food & Drug Administration (FDA) is warning that Invokana and other type 2 diabetes drugs from the SGLT2 inhibitor class may increase the risk of diabetic ketoacidosis (DKA), a severe and potentially fatal side effect that occurs when...